Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / cara therapeutics 200 upside possible with fda appro

GNHAF - Cara Therapeutics: 200% Upside Possible With FDA Approval

Vifor Pharma AG
  • The PDUFA action date for Cara’s main drug KORSUVA (treats pruritus) is August 23, 2021.
  • If KORSUVA is approved, Cara would have sole access to a large patient market with no FDA-approved therapy.
  • I calculate Cara to be extremely undervalued by P/S and PEG valuations and assuming drug approval in my forecast.

For further details see:

Cara Therapeutics: 200% Upside Possible With FDA Approval
Stock Information
Company Name: Vifor Pharma AG
Stock Symbol: GNHAF
Market: OTC
Menu
GNHAF GNHAF Quote GNHAF Short GNHAF News GNHAF Articles GNHAF Message Board
Get GNHAF Alerts

News, Short Squeeze, Breakout and More Instantly...